Lymphoma
Lymphoma is a malignant tumor originating from lymph nodes or lymphatic tissues. The main clinical manifestation is painless, progressive lymphadenopathy. The disease can occur at any age, but the peak age of onset is between 31 and 40 years old, with the peak of non-Hodgkin's lymphoma slightly earlier. The male-to-female ratio is 2-3:1.
-
Site of disease:
lymph -
Infectious :
Not contagious -
Frequent population:
Young Adults -
Related symptoms:
Lymph node enlargement hepatosplenomegaly weight loss night sweats persistent fever
Related Drugs
Ifosfamide
Indication: 1. This product has a wide anti-tumor spectrum and is mainly suitable for soft tissue tumors, testicular tumors, malignant lymphomas, lung cancer, breast cancer, ovarian cancer, cervical cancer and childhood tumors; 2. Used for anti-tumor: leukemia, spermatogonial testicular cancer, lung cancer, non-Hodgkin's lymphoma, cervical cancer, ovarian cancer and recurrent and refractory solid tumors.
Manufacturer:
Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical Co., Ltd.
Ifosfamide
Indication: 1. This product has a wide anti-tumor spectrum and is mainly suitable for soft tissue tumors, testicular tumors, malignant lymphomas, lung cancer, breast cancer, ovarian cancer, cervical cancer and childhood tumors; 2. Used for anti-tumor: leukemia, spermatogonial testicular cancer, lung cancer, non-Hodgkin's lymphoma, cervical cancer, ovarian cancer and recurrent and refractory solid tumors.
Manufacturer:
Guangdong Lingnan Pharmaceutical Co., Ltd.
Ifosfamide
Indication: 1. This product has a wide anti-tumor spectrum and is mainly suitable for soft tissue tumors, testicular tumors, malignant lymphomas, lung cancer, breast cancer, ovarian cancer, cervical cancer and childhood tumors; 2. Used for anti-tumor: leukemia, spermatogonial testicular cancer, lung cancer, non-Hodgkin's lymphoma, cervical cancer, ovarian cancer and recurrent and refractory solid tumors.
Recombinant human interferon α2b for injection
Indication: It can be used to treat acute and chronic viral hepatitis (type B, type C, etc.), genital warts, hairy cell leukemia, chronic myeloid leukemia, lymphoma, AIDS-related Kaposi's sarcoma, malignant melanoma and other diseases.
Manufacturer:
Anhui Anke Biotechnology (Group) Co., Ltd.
Nimustine hydrochloride
Indication: Relieve the subjective symptoms and signs of the following diseases: brain and neck cancer, brain tumors, lung cancer, digestive tract cancer (gastric cancer, colon/rectum cancer, esophageal cancer), malignant lymphoma and leukemia, etc.
Manufacturer:
Hainan General Alliance Pharmaceutical Co., Ltd.
Nimustine hydrochloride
Indication: Relieve the subjective symptoms and signs of the following diseases: brain and neck cancer, brain tumors, lung cancer, digestive tract cancer (gastric cancer, colon/rectum cancer, esophageal cancer), malignant lymphoma and leukemia, etc.
Manufacturer:
Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical Co., Ltd.
Nimustine hydrochloride
Indication: Relieve the subjective symptoms and signs of the following diseases: brain and neck cancer, brain tumors, lung cancer, digestive tract cancer (gastric cancer, colon/rectum cancer, esophageal cancer), malignant lymphoma and leukemia, etc.
Nimustine hydrochloride
Indication: Relieve the subjective symptoms and signs of the following diseases: brain and neck cancer, brain tumors, lung cancer, digestive tract cancer (gastric cancer, colon/rectum cancer, esophageal cancer), malignant lymphoma and leukemia, etc.
Manufacturer:
Shandong Ruiying Pioneer Pharmaceutical Co., Ltd.
Nimustine hydrochloride
Indication: Relieve the subjective symptoms and signs of the following diseases: brain and neck cancer, brain tumors, lung cancer, digestive tract cancer (gastric cancer, colon/rectum cancer, esophageal cancer), malignant lymphoma and leukemia, etc.
Nimustine hydrochloride
Indication: Relieve the subjective symptoms and signs of the following diseases: brain and neck cancer, brain tumors, lung cancer, digestive tract cancer (gastric cancer, colon/rectum cancer, esophageal cancer), malignant lymphoma and leukemia, etc.
Manufacturer:
Fresenius Kabi (Wuhan) Pharmaceutical Co., Ltd.
Related Ingredients
-
Ifosfamide list
3778-73-2 -
INTERFERON ALFA-2B list
99210-65-8 -
Nimustine hydrochloride list
55661-38-6